We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
This Fund
S&P 500
This Quarter Est. Return
+1.7%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$16.3B
AUM Growth
+$25M
(+0.15%)
Cap. Flow
-$106M
Cap. Flow % of AUM
Cap. Flow %
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
42.65%
Holding
1,605
New
145
Increased
276
Reduced
350
Closed
72
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$126M |
| 2 |
Apple
AAPL
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$86.3M |
| 4 |
Robert Half
RHI
|
+$50M |
| 5 |
FedEx
FDX
|
+$44.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$171M |
| 2 |
H&R Block
HRB
|
+$136M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$130M |
| 4 |
Pfizer
PFE
|
+$125M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.09% |
| 2 | Healthcare | 14.47% |
| 3 | Industrials | 9.18% |
| 4 | Miscellaneous | 8% |
| 5 | Technology | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.17T
| $3.21B | 19.73% |
14,803
-42
| -0.3% | -$9.01M |
2013 Q2
12 quarters
|
|
2
Brookfield
BN
$85.5B
| $584M | 3.59% |
49,502,799
-438,017
| -0.9% | -$5.24M |
2013 Q2
12 quarters
|
|
3
Microsoft
MSFT
$3.87T
| $408M | 2.51% |
7,974,066
+108,933
| +1% | +$5.66M |
2013 Q2
12 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.17T
| $402M | 2.47% |
2,778,750
+92,851
| +3% | +$13.3M |
2013 Q2
12 quarters
|
|
|
5
Apple
AAPL
$5.08T
| $357M | 2.2% |
14,957,480
+4,144,100
| +38% | +$103M |
2013 Q2
12 quarters
|
|
6
AB InBev
BUD
$168B
| $329M | 2.02% |
2,496,455
-2,565
| -0.1% | -$323K |
2013 Q2
12 quarters
|
|
7
Johnson & Johnson
JNJ
$645B
| $322M | 1.98% |
2,654,177
-51,391
| -2% | -$5.84M |
2013 Q2
12 quarters
|
|
8
Zimmer Biomet
ZBH
$18.8B
| $306M | 1.88% |
2,618,885
-37,236
| -1% | -$4.21M |
2013 Q2
12 quarters
|
|
9
CVS Health
CVS
$121B
| $284M | 1.74% |
2,963,676
-107,149
| -3% | -$10.7M |
2013 Q2
12 quarters
|
|
10
Danaher
DHR
$162B
| $261M | 1.6% |
3,839,592
-22,931
| -0.6% | -$1.5M |
2013 Q2
12 quarters
|
|
11
Wells Fargo
WFC
$249B
| $242M | 1.49% |
5,108,465
-60,951
| -1% | -$2.97M |
2013 Q2
12 quarters
|
|
12
Honeywell
HON
$69.2B
| $236M | 1.45% |
2,258,590
-19,911
| -0.9% | -$2.05M |
2013 Q2
12 quarters
|
|
13
Aramark
ARMK
$13.8B
| $215M | 1.32% |
8,913,392
-231,504
| -3% | -$5.57M |
2014 Q2
8 quarters
|
|
14
Comcast
CMCSA
$81.1B
| $211M | 1.29% |
6,463,074
-43,734
| -0.7% | -$1.36M |
2013 Q2
12 quarters
|
|
15
Philip Morris
PM
$314B
| $176M | 1.08% |
1,729,417
-33,691
| -2% | -$3.36M |
2013 Q2
12 quarters
|
|
16
Gilead Sciences
GILD
$195B
| $169M | 1.04% |
2,031,292
+359,484
| +22% | +$31.9M |
2013 Q2
12 quarters
|
|
|
17
Pfizer
PFE
$173B
| $163M | 1% |
4,882,141
-3,903,648
| -44% | -$125M |
2013 Q2
12 quarters
|
|
|
AGN
18
DELISTED
Allergan plc
AGN
| $160M | 0.99% |
694,036
+374,443
| +117% | +$86.3M |
2014 Q1
9 quarters
|
|
19
Oracle
ORCL
$381B
| $153M | 0.94% |
3,746,761
-785,082
| -17% | -$31.3M |
2013 Q2
12 quarters
|
|
|
20
Newell Brands
NWL
$2.44B
| $136M | 0.83% |
2,796,704
+2,690,434
| +2,532% | +$126M |
2016 Q1
1 quarter
|
|
21
American International
AIG
$43.4B
| $134M | 0.82% |
2,528,755
-68,318
| -3% | -$3.77M |
2013 Q2
12 quarters
|
|
22
3M
MMM
$90.5B
| $132M | 0.81% |
904,798
-5,979
| -0.7% | -$843K |
2013 Q2
12 quarters
|
|
23
Accenture
ACN
$158B
| $131M | 0.81% |
1,160,233
-22,838
| -2% | -$2.65M |
2013 Q2
12 quarters
|
|
24
IBM
IBM
$238B
| $126M | 0.77% |
865,562
-6,201
| -0.7% | -$888K |
2013 Q2
12 quarters
|
|
25
Service Corp International
SCI
$11.4B
| $125M | 0.77% |
4,619,850
+73,257
| +2% | +$1.93M |
2015 Q1
5 quarters
|
|
Similar funds
First Manhattan's Q2 2016 Portfolio in Review
As of Q2 2016, First Manhattan held 1,605 positions worth $16.3B, up 0.15% from $16.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Manhattan's Q2 2016 filing shows 145 new, 276 increased, 350 reduced and 72 closed positions. Its largest new stake was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 1,402,090 shares worth $33M. The largest sale was Perrigo, an estimated $171M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 1,402,090 shares worth $33M.
- First Manhattan added most to Newell Brands in Q2 2016, an estimated $126M increase.
- First Manhattan's biggest Q2 2016 reduction was Perrigo, cutting an estimated $171M.
- First Manhattan fully exited JARDEN CORPORATION in Q2 2016, selling an estimated $130M.
- First Manhattan's ten largest holdings make up 43% of its $16.3B portfolio in Q2 2016.
- First Manhattan opened 145 new positions and closed 72 in Q2 2016.
- First Manhattan's portfolio value rose 0.15% quarter-over-quarter to $16.3B.
Based on First Manhattan's 13F filing for Q2 2016, filed 14 Jul 2016.